← Eichor
Study identifier: NCT04851470 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Periodontal Assessment of a Bariatric Care Population

Condition: Bariatric Surgery Candidate · Obesity  ·  Sponsor: Queen Mary University of London

PhaseN/A
Planned participants394
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Our primary aim is to investigate the prevalence and severity of Periodonotal Disease (PD) in a population of obese patients. Our secondary objectives are to: Investigate inflammatory biomarkers that have been associated with PD in the saliva of obese patients. Investigate the association of FTO gene (Obesity) polymorphisms with the prevalence of PD in this population. Investigate and describe the subgingival microbial flora in obese patients with PD from subgingival dental plaque samples as well as the salivary samples.

This description comes directly from the study's public registry record.

Talk to the study team

Vandana Luthra, Dr.  ·  02078826348  ·  BHNT.Clinicaloralresearchcentre@nhs.net

Always discuss trial participation with your own doctor first.

Locations (4)

Barts Health NHS Trust Dental HospitalLondon, United KingdomRecruiting
Centre for Oral Clinical Research (COCR)London, United KingdomRecruiting
St Bartholomew's Hospital, Barts Health NHS TrustLondon, United KingdomRecruiting
Luton and Dunstable University HospitalLuton, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04851470